Further, we have recently confirmed in a larger patient cohort that apart from the levels being highest in HF patients with reduced ejection fraction with PH, plasma VEGF-D elevations were also found in PAH and CTEPH patients compared to healthy controls [38]. The gene discussed is VEGFD; the disease is chronic thromboembolic pulmonary hypertension.